Essai clinique
Récupéré
Publication
clinicaltrials.gov
Holland Bloorview Kids Rehabilitation Hospital, United States Department of Defense
(2013).
Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD).
ClinicalTrials.gov.
Holland Bloorview Kids Rehabilitation Hospital.
- Date de publication
-
2013
- Identifiant
-
NCT01908205
- Auteurs
-
Holland Bloorview Kids Rehabilitation Hospital,
United States Department of Defense
- Source
- ClinicalTrials.gov
- Type de référence
- clinical_trial
- Éditeur
- Holland Bloorview Kids Rehabilitation Hospital
- Source de métadonnées
- clinicaltrials.gov
Résumé
We are studying an investigational drug called intranasal oxytocin (Syntocinon®). Syntocinon® has been approved by the U.S. Food and Drug Administration for use in helping women breastfeed, but it has not been approved for use in children with ASD. However, there is previous research conducted that has indicated that after administration of oxytocin, adults with ASD demonstrated improvements in social cognition, and reduced repetitive behaviours and anxiety. There is also early research to suggest that children may also benefit in these areas. The purpose of this study is to test if oxytocin works to help children and adolescents with ASD.